NCI-EORTC-AACR news: WP-769, a new oral doxorubicin analogue with an improved biological profile Nov. 13, 2000
Inhibitors of cell cycle kinases and their use as anticancer agents disclosed in recent patent Nov. 10, 2000
Second-generation tubulin-binding antitumor agent T-900607: design and characterization Nov. 10, 2000
RSS